Viking Therapeutics
VKTX
#2409
Rank
A$9.48 B
Marketcap
$85.15
Share price
-9.14%
Change (1 day)
447.20%
Change (1 year)

Viking Therapeutics (VKTX) - Total liabilities

Total liabilities on the balance sheet as of September 2024 : A$40.89 Million

According to Viking Therapeutics 's latest financial reports the company's total liabilities are A$40.89 Million. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Viking Therapeutics - Total liabilities on balance sheet (from 2014 to 2024)

Total liabilities by year

Year Total liabilities Change
2023-12-31A$29.45 M-13.61%
2022-12-31A$34.1 M181.66%
2021-12-31A$12.1 M-23.42%
2020-12-31A$15.81 M55.11%
2019-12-31A$10.19 M57.41%
2018-12-31A$6.47 M-41.6%
2017-12-31A$11.08 M23.11%
2016-12-31A$9 M-2.27%
2015-12-31A$9.21 M-70.03%
2014-12-31A$30.75 M6265.43%
2013-12-31A$0.48 M376.34%
2012-12-31A$0.1 M

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
A$1.83 B 4,385.70%๐Ÿ‡บ๐Ÿ‡ธ USA
A$1.35 B 3,211.51%๐Ÿ‡บ๐Ÿ‡ธ USA